Sam Chun Dang Pharm. financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
₩0.00M ₩52.57B ₩47.51B ₩56.02B ₩60.64B ₩67.94B ₩74.60B ₩77.57B ₩76.65B ₩104.54B ₩118.92B ₩132.06B ₩147.37B ₩160.59B ₩159.96B ₩186.60B ₩166.86B ₩167.27B ₩177.34B ₩0.00M ₩0.00M
GM % Gross Margin %
0.00% 62.61% 62.18% 64.77% 64.68% 58.73% 100.00% 52.94% 49.46% 53.97% 54.70% 54.40% 53.54% 52.62% 51.87% 59.21% 56.20% 49.52% 50.54% 0.00% 0.00%
OM Operating Margin
0.00% 13.66% 4.66% 12.07% 10.63% 8.42% 9.61% 9.67% 7.12% 15.17% 15.93% 15.73% 16.53% 14.93% 9.69% 13.51% 2.58% -9.14% 7.09% 0.00% 0.00%
EPS Earnings Per Share
₩69.00 ₩449.00 ₩572.00 ₩553.00 ₩413.00 ₩488.00 ₩-45.00 ₩0.00
Div. Dividends
₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩75.00 ₩50.00 ₩50.00 ₩0.00 ₩50.00 ₩50.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00 ₩0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 13.11% 9.04% 12.11% 0 0 10.25% -0.00% 0 0 0 0
Sha. Shares
18.64m 20m 20m 20m 19.3m 19.3m 19.3m 19.3m 19.3m 19.3m 20.35m 20.54m 21.3m 21.41m 21.41m 21.41m 22.07m 22.07m 22.07m 22.76m 22.76m
OCF Operating Cash Flow
₩0.00M ₩6.99B ₩5.30B ₩7.49B ₩3.70B ₩8.06B ₩0.00M ₩11.35B ₩1.60B ₩15.94B ₩19.55B ₩17.34B ₩17.76B ₩26.09B ₩25.03B ₩30.60B ₩3.25B ₩-7706.97M ₩13.28B ₩0.00M ₩0.00M
FCF Free Cash Flow
₩0.00M ₩4.30B ₩-9516.24M ₩4.08B ₩447.51M ₩733.97M ₩0.00M ₩9.50B ₩-1258.04M ₩11.66B ₩5.42B ₩8.69B ₩13.66B ₩22.83B ₩12.48B ₩24.01B ₩-5429.09M ₩-22588.77M ₩-3252.42M ₩0.00M ₩0.00M
FCFS Free Cash Flow Per Share
₩0.00 ₩142.09 ₩-491.30 ₩170.23 ₩1.67 ₩-19.39 ₩0.00 ₩466.85 ₩-93.19 ₩582.64 ₩442.67 ₩328.42 ₩424.28 ₩840.37 ₩277.24 ₩1.00k ₩-394.53 ₩-1677.25 ₩-1507.47 ₩0.00 ₩0.00